surpass cvot tirzepatide 💡 New insight in diabetes care: In patients with T2DM and ASCVD, the SURPASS-CVOT trial found that was noninferior to dulaglutide for major cardiovascular events (12.2% vs 13.1%; HR 0.92). What SURPASS-CVOT Shows Mounjaro Surpasses Trulicity

A 266% increased risk of deep vein thrombosis

1.39k views 45 slides Aim: Learn about causes and effects of ozone depletion Aim: Learn about causes and effects of ozone depletion New words: ozone, ozone layer, troposphere, stratosphere, U.V

Membranes (Basel) , 13 (4), 441

Feb 28, 2026 Before you panic about that red bump forming around your injection site, take a breath

So an important component of treating MCAS is soothing these mast cells and helping them return to a balanced state

This effect is believed to stem from semaglutides impact on inflammatory pathways, though more research is needed to fully understand how it may influence RA symptoms